Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 22, 2024Annals of Surgical OncologyOpen Access

The Value of Biological and Conditional Factors for Staging of Patients with Resectable Pancreatic Cancer Undergoing Upfront Resection: A Nationwide Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

TSThijs J. SchoutenIGIris W.J.M. van GoorGDGalina Dorland

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schouten et al. (2024) studied this question.

synapsesocial.com/papers/68e780b7b6db6435876f3617https://doi.org/10.1245/s10434-024-15070-w
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic factors for resectable pancreatic adenocarcinoma: a systematic review and meta-analysis2026
  2. 2Predicting resectability after neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer: a single center, retrospective trial2025
  3. 3Biological Borderline Resectable Pancreatic Cancer Represents a Genetically and Immunologically Aggressive Subtype2026
  4. 4Upfront surgery versus neoadjuvant chemotherapy in resectable pancreatic adenocarcinoma.2026
  5. 5Prognostic Determinants of Overall Survival After Resection for Pancreatic Ductal Adenocarcinoma: A Consensus‐Based Conceptual Framework2026